Abstract
We describe a pediatric cystic fibrosis patient who developed a pulmonary exacerbation due to two multidrug-resistant (MDR) Pseudomonas aeruginosa isolates. In addition to these MDR organisms, the case was further complicated by β-lactam allergy. Despite the MDR phenotype, both isolates were susceptible to an antimicrobial combination.
Original language | English |
---|---|
Pages (from-to) | 5627-5630 |
Number of pages | 4 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 60 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2016 |
Externally published | Yes |